Corporate Banner
Satellite Banner
Technology Networks Header
Sunday, October 26, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Claritas Genomics Launches Next Generation Sequencing Panel
Saturday, September 13, 2014
ClariFocus Panel to detect genetic causes of nephrotic syndrome in children.

GE Healthcare Life Sciences Launches illustra™ Single Cell GenomiPhi
Tuesday, September 02, 2014
Delivering high quality gDNA from a single cell.

Agilent Technologies Introduces Next-Generation Sequencing Cancer Research Panels
Tuesday, September 02, 2014
High-performance ClearSeq AML to be followed by series of focused, comprehensive gene panels for cancer research.

Eurofins Genomics Adds NGS to ISO17025 Accredited Testing Portfolio
Saturday, August 16, 2014
ISO17025 accreditation to consistently offer valid results for testing in the fields of veterinary medicine, pharmaceuticals, food and animal feed, commodities and health care.

Bioo Scientific First to Address Small RNA-Seq Bias Concerns
Wednesday, August 13, 2014
Company launches NEXTflex™ Small RNA Sequencing Kit v2.

Merck Millipore Introduces Magna™ Nuclear RIP Kits
Tuesday, August 05, 2014
Facilitates isolation and analysis of RNA molecules associated with chromatin.

Bioo Scientific Launches 16S V1 – V3 rRNA Library Prep Kits for Bacterial Metagenomics Studies
Wednesday, July 23, 2014
This kit allows users to go from sample to sequence in two hours, making it the fastest library prep kit available.

ChIP Sequencing Kit for Next Generation Sequencing
Tuesday, July 22, 2014
Company extends the benefits of their Chromatrap® solid state ChIP technology.

QIAGEN Launch of 14 New Cancer Gene Panels
Wednesday, July 16, 2014
QIAGEN introduces 14 new panels for targeted enrichment of up to 570 clinically-relevant genes, expands largest portfolio of panels for assessing cancer genes.

<< 1 2 3 4 5 6 7 >>
Showing Results 11 - 20 of 213
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv